跳至主要内容
临床试验/IRCT20181005041239N1
IRCT20181005041239N1招募中3 期

Study the radioprotective effects of oral atorvastatin on side effects and effectiveness of radiotherapy in patients with breast cancer: A randomized clinical trial, evaluate of oxidative stress biomarkers and quality of life

Sari University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Have the ability to read and write in farsi or be able to communicate if they are illiterate.
  • Women aged 18 and over
  • Women with breast cancer who receive radiation dosage during treatment with the standard technique of bilateral tangent 5000CG / 25F Photon.
  • Awareness of the person, time and place
  • The possibility of making direct telephone calls to a patient or an active member of his family (to follow the samples)
  • Based on bra / breast size =85
  • Women without known diseases and under medical treatmentSuch as diabetes, thyroid disorders, known liver disease, immune system weakness, rhabdomyolysis and cardiovascular disease, hyperlipidemia, depression and anxiety and taking statins with a doctor's order.
  • Not using a psychologist or psychiatrist's counsel at the time of the study or at least a month before the study begins.

排除标准

  • Allergy to atorvastatin
  • Taking anti-inflammatory drugs
  • Addicted to alcohol, cigarettes and drugs

研究者

发起方
Sari University of Medical Sciences

相似试验